Porrata LF - Search Results

1

The dynamic human immune response to cancer: it might just be rocket science.

Holtan SG, Dronca RS, Nevala WK, Porrata LF, Mansfield AS, Block MS, Leontovich AA, Grotz TE, Turner JD, Frisch HP, Markovic SN. Holtan SG, et al. Among authors: porrata lf. Immunotherapy. 2011 Sep;3(9):1021-4. doi: 10.2217/imt.11.109. Immunotherapy. 2011. PMID: 21913823 No abstract available.

2

Immune reconstitution after autologous hematopoietic stem cell transplantation.

Porrata LF, Litzow MR, Markovic SN. Porrata LF, et al. Mayo Clin Proc. 2001 Apr;76(4):407-12. doi: 10.4065/76.4.407. Mayo Clin Proc. 2001. PMID: 11322356 Review.

3

Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation.

Porrata LF, Gastineau DA, Padley D, Bundy K, Markovic SN. Porrata LF, et al. Leuk Lymphoma. 2003 Jun;44(6):997-1000. doi: 10.1080/1042819031000077089. Leuk Lymphoma. 2003. PMID: 12854901 Clinical Trial.

4

Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation.

Porrata LF, Markovic SN. Porrata LF, et al. Clin Exp Med. 2004 Oct;4(2):78-85. doi: 10.1007/s10238-004-0041-4. Clin Exp Med. 2004. PMID: 15672944 Review.

5

Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.

Holtan SG, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Litzow MR, Gastineau DA, Markovic SN. Holtan SG, et al. Among authors: porrata lf. Br J Haematol. 2006 Jun;133(6):628-33. doi: 10.1111/j.1365-2141.2006.06088.x. Br J Haematol. 2006. PMID: 16704437 Free PMC article.

6

Androgenic therapy for Waldenstrom's macroglobulinemia.

Porrata LF, Markovic SN. Porrata LF, et al. Am J Hematol. 2006 Nov;81(11):892-3. doi: 10.1002/ajh.20581. Am J Hematol. 2006. PMID: 16783787 Free article. No abstract available.

7

AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma.

Holtan SG, Porrata LF, Micallef IN, Padley DJ, Inwards DJ, Ansell SA, Johnston PB, Gastineau DA, Markovic SN. Holtan SG, et al. Among authors: porrata lf. Clin Lymphoma Myeloma. 2007 Jan;7(4):315-8. doi: 10.3816/clm.2007.n.009. Clin Lymphoma Myeloma. 2007. PMID: 17324341 Clinical Trial.

8

mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD).

Holtan SG, Porrata LF, Colgan JP, Zent CS, Habermann TM, Markovic SN. Holtan SG, et al. Among authors: porrata lf. Am J Hematol. 2008 Aug;83(8):688-9. doi: 10.1002/ajh.21216. Am J Hematol. 2008. PMID: 18528858 Free article. No abstract available.

9

Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count.

Jacobs NL, Holtan SG, Porrata LF, Markovic SN, Tefferi A, Steensma DP. Jacobs NL, et al. Among authors: porrata lf. Am J Hematol. 2010 Mar;85(3):160-3. doi: 10.1002/ajh.21618. Am J Hematol. 2010. PMID: 20131304 Free article.

10

Treatment with polyclonal immunoglobulin during T-cell reconstitution promotes naive T-cell proliferation.

Pires AE, Afonso AF, Queirós A, Cabral MS, Porrata L, Markovic SN, Kaveri SV, da Silva MG, João C. Pires AE, et al. J Immunother. 2010 Jul-Aug;33(6):618-25. doi: 10.1097/CJI.0b013e3181d3cb19. J Immunother. 2010. PMID: 20551835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters